BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15864375)

  • 1. Correlation of epidermal growth factor receptor expression with tumor microdensity vessels and with vascular endothelial growth factor expression in ovarian carcinoma.
    Raspollini MR; Castiglione F; Garbini F; Villanucci A; Amunni G; Baroni G; Boddi V; Taddei GL
    Int J Surg Pathol; 2005 Apr; 13(2):135-42. PubMed ID: 15864375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates.
    Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL
    Oncol Rep; 2004 Feb; 11(2):309-13. PubMed ID: 14719060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
    Rubatt JM; Darcy KM; Hutson A; Bean SM; Havrilesky LJ; Grace LA; Berchuck A; Secord AA
    Gynecol Oncol; 2009 Mar; 112(3):469-74. PubMed ID: 19135712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian serous carcinoma: relationship of p53 and bcl-2 with tumor angiogenesis and VEGF expression.
    Crasta JA; Mishra S; Vallikad E
    Int J Gynecol Pathol; 2011 Nov; 30(6):521-6. PubMed ID: 21979585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
    Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
    Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma.
    Raspollini MR; Amunni G; Villanucci A; Baroni G; Boddi V; Taddei GL
    Int J Gynecol Cancer; 2004; 14(5):815-23. PubMed ID: 15361189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor.
    Hata K; Fujiwaki R; Nakayama K; Maede Y; Fukumoto M; Miyazaki K
    Anticancer Res; 2000; 20(5C):3941-9. PubMed ID: 11268481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
    Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
    Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD105 microvessels density, VEGF, EGFR-1 and c-erbB-2 and their prognostic correlation in different subtypes of cervical adenocarcinoma.
    Barbu I; Crăiţoiu S; Simionescu CE; Drâgnei AM; Mărgăritescu C
    Rom J Morphol Embryol; 2013; 54(3):519-30. PubMed ID: 24068399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma.
    Ogawa S; Kaku T; Kobayashi H; Hirakawa T; Ohishi Y; Kinukawa N; Nakano H
    Cancer Lett; 2002 Feb; 176(1):111-8. PubMed ID: 11790460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
    Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of GLUT-1 in epithelial ovarian carcinoma: correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction.
    Semaan A; Munkarah AR; Arabi H; Bandyopadhyay S; Seward S; Kumar S; Qazi A; Hussein Y; Morris RT; Ali-Fehmi R
    Gynecol Oncol; 2011 Apr; 121(1):181-6. PubMed ID: 21167567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.
    Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR
    Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
    Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
    J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma.
    Raica M; Cimpean AM; Anghel A
    Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of microvessel density and vascular endothelial growth factor expression in sinonasal carcinomas.
    Valente G; Mamo C; Bena A; Prudente E; Cavaliere C; Kerim S; Nicotra G; Comino A; Palestro G; Isidoro C; Beatrice F
    Hum Pathol; 2006 Apr; 37(4):391-400. PubMed ID: 16564912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
    Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
    Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor expression and neovascularization in non--small cell lung carcinoma.
    Ozbudak IH; Ozbilim G; Kucukosmanoglu I; Dertsiz L; Demircan A
    Int J Surg Pathol; 2009 Oct; 17(5):390-5. PubMed ID: 18849317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.